Our study provides evidence for a potential tumor-suppressing function of NR1D1 in RB, based on the novel findings that low expression levels of NR1D1 associated with advanced disease stage and choroidal and optic nerve infiltration. This evidence concerns the gene NR1D1 and neoplasm.